Honestly? I can't advise on that. However, if they can show that the results were clearly wrong or swapped, then they could suggest a revise of the results based on their other patient data. This would be significant IMO.
As Vince said, the outcome is consistent across all dosages in both lesions. In both data sets.
The difference is the vehicle.
They really need to work out the EXACT reason....
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-239
-
- There are more pages in this discussion • 412 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.020(4.94%) |
Mkt cap ! $702.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.0¢ | $2.321M | 5.975M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 178216 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 261051 | 14 |
View Market Depth
| Last trade - 12.59pm 18/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |